This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
About this article
Cite this article
Bevacizumab plus sunitinib in metastatic RCC leads to 'supra-additive' toxicity. React. Wkly. 1243, 2 (2009). https://doi.org/10.2165/00128415-200912430-00002
- Vascular Endothelial Growth Factor
- Renal Cell Carcinoma